A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

Dr Harriet Treacy, co-founder of Beyondbmi, spoke with EVOKE to explain that obesity is a disease that requires medical treatment, whereas many people are simply availing of the drugs to lose a few ...

Fashion influencer Remi Bader just revealed she underwent a weight loss surgery that cut 80 percent of her stomach amid ...

A new University of Michigan study shows that a strong majority of older Americans want health insurance — including Medicare — to cover weight loss medica ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...

Former Citigroup CEO Sandy Weill has donated $50 million to launch a cancer research hub focusing on how diet and metabolism ...

Collective Health, a leader in employee health benefits, and digital healthcare leader Noom’s enterprise division, Noom Health, have partnered to deliver Collective Health + Noom Med with SmartRx, an ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...